{
  "content": "Multiple randomized, controlled studies have established the efficacy of amiodarone for maintenance of sinus rhythm in AF and have shown amiodarone to be superior to other antiarrhythmic agents. In SAFE-T (Sotalol Amiodarone Atrial Fibrillation Efficacy Trial), amiodarone was superior to sotalol and placebo with respect to median time to recurrence of AF (487 versus 74 versus 6 days, respectively; P<0.001, for amiodarone versus placebo and amiodarone versus sotalol).17 In CTAF (Canadian Trial of Atrial Fibrillation), AF recurrence rates at 16 months were 35% in the amiodarone group and 63% in those randomized to combined propafenone or sotalol (P<0.001).19 However, the adverse effects profile of amiodarone is onerous",
  "source": "https://www.jacc.org/doi/10.1016/j.jacc.2023.08.017",
  "chunk_id": "38ed0197-a724-4d40-9621-17590936d506",
  "similarity_score": 0.4372698664665222,
  "query": "atrial fibrillation recurrence rates maintenance therapy amiodarone beta-blockers long-term outcomes rhythm maintenance",
  "rank": 2,
  "title": "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines",
  "authors": "JosÃ© A. Joglar, Mina K. Chung, Anastasia L. Armbruster, Emelia J. Benjamin, Janice Y. Chyou, Edmond M. Cronin, Anita Deswal, Lee L. Eckhardt, Zachary D. Goldberger, Rakesh Gopinathannair, Bulent Gorenek, Paul L. Hess, Mark Hlatky, Gail Hogan, Chinwe Ibeh, Julia H. Indik, Kazuhiko Kido, Fred Kusumoto, Mark S. Link, Kathleen T. Linta, Gregory M. Marcus, Patrick M. McCarthy, Nimesh Patel, Kristen K. Patton, Marco V. Perez, Jonathan P. Piccini, Andrea M. Russo, Prashanthan Sanders, Megan M. Streur, Kevin L. Thomas, Sabrina Times, James E. Tisdale, Anne Marie Valente, David R. Van Wagoner",
  "year": "2023",
  "journal": "JACC",
  "reference": "Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., Gorenek, B., Hess, P. L., Hlatky, M., Hogan, G., Ibeh, C., Indik, J. H., Kido, K., Kusumoto, F., Link, M. S., Linta, K. T., Marcus, G. M., McCarthy, P. M., Patel, N., Patton, K. K., Perez, M. V., Piccini, J. P., Russo, A. M., Sanders, P., Streur, M. M., Thomas, K. L., Times, S., Tisdale, J. E., Valente, A. M., & Van Wagoner, D. R. (2023). 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. JACC, 83(1). Not available.",
  "doi": "Not available",
  "chunk_index": 654,
  "total_chunks": 1610,
  "retrieved_at": "2025-07-24T21:58:13.326109"
}